Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Cancer Res ; 11(3): 1302-11, 2005 Feb 01.
Article in English | MEDLINE | ID: mdl-15709202

ABSTRACT

PURPOSE: An ideal vaccine therapy for tumors should activate both effector and memory immune responses against tumor-specific antigens. Here we investigated the effect of CpG oligodeoxynucleotides (CpG-ODN) for their ability to potentiate the activity of tumor antigen-pulsed bone marrow-derived dendritic cells (DC) in a vaccine model for the treatment of murine renal cell carcinoma (RENCA). EXPERIMENTAL DESIGN: First we evaluated the effects of a murine renal cell carcinoma (RENCA) on immune cell activity in a mouse model using in vitro assays for T-cell proliferation and natural killer cell activation. To overcome the immune suppression of the tumor, we s.c. injected groups of 10 mice with dendritic cells and tumor cells. We compared the effect of different conditioning regimens of the DCs with RENCA antigen and/or CpG-ODNs before injection by measuring tumor size twice a week. RESULTS: Tumor growth was shown to negatively affect spleen cell and T-cell proliferation, IFN-gamma production, natural killer cell activity, and NF-kappaB activation in T cells. In this model, we have shown that RENCA-pulsed CpG-ODN-treated DCs were able not only to significantly reduce tumor growth but also to prevent tumor implantation in 60% of mice. Tumor-free mice were resistant to tumor challenge and the immunity conferred by the vaccine was transferable and tumor specific. CONCLUSIONS: This data show that RENCA down-modulates the immune response, and DC vaccine therapy, in conjunction with CpG-ODN, can restore tumor-specific immunity.


Subject(s)
Carcinoma, Renal Cell/therapy , Dendritic Cells/immunology , Immunotherapy, Adoptive/methods , Kidney Neoplasms/therapy , Oligodeoxyribonucleotides/pharmacology , Adjuvants, Immunologic/pharmacology , Adjuvants, Immunologic/therapeutic use , Analysis of Variance , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/immunology , Carcinoma, Renal Cell/immunology , Carcinoma, Renal Cell/pathology , Cell Line, Tumor , CpG Islands/genetics , Dendritic Cells/cytology , Kidney Neoplasms/immunology , Kidney Neoplasms/pathology , Mice , Mice, Inbred BALB C , Neoplasm Transplantation , Oligodeoxyribonucleotides/immunology , Oligodeoxyribonucleotides/therapeutic use , T-Lymphocytes/cytology , T-Lymphocytes/immunology , Treatment Outcome
2.
Eur J Immunol ; 32(11): 3315-25, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12555677

ABSTRACT

Collaborative interactions between B lymphocytes and CD4+ helper T cells are necessary for the induction of Ab responses to most protein Ag and for the generation of memory B cells in germinal centers. To study the role of the CD4 molecule in the germinal center response and in the development of B cell memory, we have investigated T helper function in the initiation and maturation of humoral immunity in CD4-deficient mice. In the absence of CD4+ T cells, immunization with thymus-dependent Ag was able to induce germinal center formation and Ig somatic hypermutation. In addition, Ag-driven affinity maturation and development of B cell memory were largely intact in CD4-deficient mice. Thus, CD4-deficient T helper cells are able to collaborate with Ag-activated B cells to elicit the germinal center reaction, switch on the mutational machinery, and deliver signals necessary for B cell memory development.


Subject(s)
Antibody Affinity , B-Lymphocytes/immunology , CD4 Antigens/physiology , Germinal Center/physiology , Immunologic Memory , Somatic Hypermutation, Immunoglobulin , T-Lymphocytes, Helper-Inducer/physiology , Animals , Female , Genes, Immunoglobulin , Immunization , Immunophenotyping , Male , Mice , Mice, Inbred C57BL , Receptors, Antigen, T-Cell, alpha-beta/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...